References
- McGarrity TJ, Amos CI, Baker MJ, et al. Peutz-Jeghers syndrome. 2001 Feb 23 [updated 2016 Jul 14]. In: Adam MP, Ardinger HH, Pagon RA, editors. GeneReviews® [internet]. Seattle (WA): University of Washington, Seattle; 1993. 2020.
- Burt RW. Polyposis syndromes. Clin Perspect Gastroenterol. 2002;5:51–59.
- Young RH, Welch WR, Dickersin GR, et al. Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with Adenoma malignum of the cervix. Cancer. 1982;50(7):1384–1402.
- Gilks CB, Young RH, Aguirre P, et al. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol. 1989;13(9):717–729.
- Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health. 2012;21(10):1031–1037.
- Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer (IARC); 2014.
- Nishio S, Mikami Y, Tokunaga H, et al. Analysis of gastric-type mucinous carcinoma of the uterine cervix — an aggressive tumor with a poor prognosis: a multi-institutional study. Gynecologic Oncology. 2019;153(1):13–19.
- Kojima A, Mikami Y, Sudo T, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol. 2007;31(5):664–672.
- FIGO Cancer report 2018, Int J Gynecol Obstet. 2018;143 (Suppl 2):2–3.
- Lalit K, Sudeep G. Integrating chemotherapy in the management of cervical cancer: a critical appraisal. Oncology. 2016;91(suppl 1):8–17.
- Lapresa M, Parma G, Portuesi R, et al. Neoadjuvant chemotherapy in cervical cancer: an update. Expert Rev Anticancer Ther. 2015;15(10):1171–1181.
- Emily M, Marisa N. Peutz-Jeghers syndrome pathobiology, pathologic manifestations, and suggestions for recommending genetic testing in. Pathol Re Surg Pathol. 2016;9:243–268.
- Jeghers H, McKusick KV, Katz KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med. 1949;241(26):1031–1036.
- Riegert-Johnson D, Ferga CG, Westra W, et al. Peutz-jeghers syndrome. In: Riegert-Johnson DL, Boardman LA, Hefferon T, et al. editors. Cancer syndromes. Bethesda (MD): National Center for Biotechnology Information; 2009.
- Beggs AD, Latchford AR, Vasen HF, Moslein G, et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59(7):975–986.
- Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998;18(1):38–43.
- Aretz S, Stienen D, Uhlhaas S, et al. High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat. 2005;26(6):513–519.
- Daniell J, Plazzer J-P, Perera A, et al. An exploration of genotype-phenotype link between Peutz-Jeghers syndrome and STK11: a review. Fam Cancer. 2018;17(3):421–427.
- McGarrity TJ, Kulin HE, Zaino RJ. Peutz-Jeghers syndrome. Am J Gastroenterol. 2000;95(3):596–604.
- Banno K, Kisu I, Yanokura M, et al. Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (review). Oncol Lett. 2013;6(5):1184–1188.
- Garg K, Karnezis A, Rabban J. Uncommon hereditary gynaecological tumour syndromes: pathological features in tumours that may predict risk for a germline mutation. Pathology. 2018;50(2):238–256.
- Ferry JA, Young RH, Engel G, et al. Oxyphilic sertoli cell tumor of the ovary: a report of three cases, two in patients with the Peutz-Jeghers syndrome. Int J Gynecol Pathol. 1994;13(3):259–266.
- Chen KT. Female genital tract tumors in Peutz-Jeghers syndrome. Hum Pathol. 1986;17(8):858–861.
- Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119(6):1447–1453.
- Kawakami F, Mikami Y, Kojima A, et al. Diagnostic reproducibility in gastric-type mucinous adenocarcinoma of the uterine cervix: validation of novel diagnostic criteria. Histopathology. 2010;56(4):551–553.
- Zhang Y, Liang L, Euscher E, et al. Gastric-type mucinous adenocarcinoma of the uterine cervix with neoadjuvant therapy mimicking clear cell carcinoma. Int J Clin Exp Pathol. 2015;8(9):11798–11803.
- Nara M, Hashi A, Murata S, et al. Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection. Gynecol Oncol. 2007;106(2):289–298.
- Kusanagi Y, Kojima A, Mikami Y, et al. Absence of high-risk human papillomavirus (HPV) detection in endocervical adenocarcinoma with gastric morphology and phenotype. Am J Pathol. 2010;177(5):2169–2175.
- Wada T, Ohishi Y, Kaku T, et al. Endocervical adenocarcinoma with morphologic features of both usual and gastric types: clinicopathologic and immunohistochemical analyses and high-risk HPV detection by in situ hybridization. Am J Surg Pathol. 2017;41(5):696–705.
- Park KJ, Kiyokawa T, Soslow RA, et al. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol. 2011;35(5):633–646.
- Ramirez PT, Frumovitz M, Pareja R, et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med. 2018;379(20):1895–1904.